Viking Therapeutics VKTX signed a broad multi-year manufacturing agreement with CordenPharma, a contract development and ...

NEW YORK, NY / ACCESS Newswire / March 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks ...

Merck (MRK) ended the recent trading session at $92.25, demonstrating a +1.84% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 1.59%.

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Fintel reports that on February 18, 2025, Deutsche Bank downgraded their outlook for Merck (WBAG:MRK) from Buy to Hold. There are 5,200 funds or institutions reporting positions in Merck.

Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.